SINOVAC BIOTECH LTD
(SVA)Financial Statements · SEC EDGAR XBRL
Revenue
$361.4M
-23.1%
EPS
$1.27
+768.4%
Gross Margin
61.1%
Op. Income
-$505.5M
+29.2%
FCF
-$152.9M
-772.4%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Cost of Revenues
Gross Profit
Operating Expenses & Income
Selling General & Admin
Research & Development
Total Operating Expenses
Operating Income
Non-Operating Income/Expense
Other Non-Operating Income
Pre-Tax Income
Income Tax Expense
Net Income
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)